期刊： TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (8)
Little is known about oropharyngeal colonization microorganisms in patients during allogeneic hematopoietic stem cell transplantation (allo-HSCT), and......
期刊： TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (11)
Graft-versus-host disease (GVHD) is an immune-mediated inflammatory disease resulting from destruction of host tissue by donor immunoreactive cells an......
期刊： TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (2)
Several studies have indicated that chimeric antigen receptor (CAR) T cell therapy followed by allogeneic hematopoietic stem cell transplantation is b......
期刊： TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (3)
Clinical outcomes of hematopoietic stem cell transplantation (HSCT) using a haploidentical stem cell graft and an unrelated umbilical cord blood unit ......
期刊： TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (7)
Myeloid-derived suppressor cells (MDSCs), a population of myeloid lineage cells with immunosuppressive capacity, can mitigate acute graft-versus-host ......
期刊： TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (9)
Severe aplastic anemia (SAA) is a life-threatening bone marrow failure disease. Allogeneic hematopoietic stem cell transplantation from a matched sibl......
期刊： TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (11)
Hitherto, the optimal timing of rabbit anti-thymocyte globulin (rATG) in matched sibling donor peripheral blood stem cell transplantation (MSD-PBSCT) ......
期刊： TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (11)
Transplantation-associated thrombotic microangiopathy (TA-TMA) is a life-threatening complication for patients undergoing hematopoietic stem cell tran......
期刊： TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (3)
Mixed chimerism (MC) and secondary graft failure (SGF) with recipient- or donor-type chimerism is a major obstacle in allogeneic hematopoietic stem ce......
期刊： TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (4)
Transplant-associated thrombotic microangiopathy (TA-TMA) has a high mortality rate and lacks effective treatments. We searched the GEO database and a......
期刊： TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (3)
Activation of antigen-presenting cells (APCs) is crucial in initiating inflammation and alloreaction during acute graft-versus-host disease (aGVHD), a......
期刊： TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (2)
Chimeric antigen receptor (CAR) T cell therapy has shown unprecedented response rates in patients with relapsed/refractory (R/R) multiple myeloma (MM)......
期刊： TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (6)
ABO incompatibility is common in hematopoietic stem cell transplantation (HSCT); however, the impact of donor-recipient ABO compatibility on transplan......
期刊： TRANSPLANTATION AND CELLULAR THERAPY, 2021; 27 (8)
Hepatitis B virus (HBV) has a high rate of chronic infection in Asian populations, and only limited studies have been performed to analyze the impact ......
期刊： TRANSPLANTATION AND CELLULAR THERAPY, 2021; 27 (8)
Marrow fibrosis (MF) is usually accompanied with primary myelodysplastic syndromes (MDS) and no consensus has been reached on the relationship between......
